X4 Pharmaceuticals, Inc. (XFOR) Financials
XFOR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 173.3 million | 105.7 million |
2023-06-30 | 173.4 million | 105.9 million |
2023-03-31 | 173.4 million | 105.9 million |
2022-12-31 | 124.4 million | 72.7 million |
XFOR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -20.8 million | 2.4 million |
2023-06-30 | -21.4 million | 2.1 million |
2023-03-31 | -21.4 million | 2.1 million |
2022-12-31 | -26.5 million | 1.6 million |
XFOR Net Income
No data available :(
XFOR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 141.7 million | - | 4.0 million |
2023-06-30 | 141.3 million | - | 4.3 million |
2023-03-31 | 141.3 million | - | 4.6 million |
2022-12-31 | 93.4 million | - | 4.8 million |
XFOR Shares Outstanding
XFOR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 8000 | 19.1 million | 8.1 million | - |
2023-06-30 | 8000 | 15.6 million | 10.2 million | - |
2023-03-31 | 8000 | 15.6 million | 7.2 million | - |
2022-12-31 | 9000 | 22.1 million | 14.4 million | 7.2 million |
XFOR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 502000 |
2023-06-30 | - | 516000 |
2023-03-31 | - | 512000 |
2022-12-31 | - | 501000 |
XFOR
Price: $1.10
52 week price:
Earnings Per Share: -0.57 USD
P/E Ratio: -1.35
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 471700
Market Capitalization: 221.7 million